Trials / Completed
CompletedNCT06054100
The Effect of Colchicine on Inflammation in ACS Patients
The Effect of Colchicine on Inflammation in Acute Coronary Syndrome Patients
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 88 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate whether the anti-inflammatory effect of colchicine is beneficial in ACS patients
Detailed description
This study will evaluate the effect of colchicine on inflammation, cardiac remodeling, and atherosclerotic risk in STEMI patients through the assessment of the IL-1β, sST2, and lipid profile parameters as well as to examine the drug safety and tolerability in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colchicine Tablets | Colchicine oral tablets loading dose of 1mg every 12 hrs for 1 day, followed by 0.5 mg BID for 3 months |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2022-02-15
- Completion
- 2022-05-20
- First posted
- 2023-09-26
- Last updated
- 2023-09-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06054100. Inclusion in this directory is not an endorsement.